Jose L. Ramirez, Lindsey S. Garver and George Dimopoulos Pages 116 - 130 ( 15 )
Malaria is one of todays most serious diseases with an enormous socioeconomic impact. While anti- malarial drugs have existed for some time and vaccines development may be underway, the most successful malaria eradication programs have thus far relied on attacking the mosquito vector that spreads the disease causing agent Plasmodium. Here we will review past, current and future perspectives of malaria vector control strategies and how these approaches have taken a promising turn thanks recent advances in functional genomics and molecular biology.
Malaria, Plasmodium, Anopheles, mosquito vector
W. Harry Feinstone Department of Molecular Microbiology and Immunology, Bloomberg School of Public Health, Johns Hopkins University, 615 N. Wolfe Street, Baltimore, MD 21205-2179, USA.